Functional status of United States children supported with a left ventricular assist device at heart transplantation

Anica Bulic1, Katsuhide Maeda2, Yulin Zhang1

  • 1Division of Pediatric Cardiology and The Heart Center Clinical and Translational Research Program, Lucile Packard Children's Hospital, Stanford University, Palo Alto, California; The Department of Pediatrics, Lucile Packard Children's Hospital, Stanford University, Palo Alto, California.

Insights

Pediatric left ventricular assist devices (LVADs) improve functional status in children awaiting heart transplant. While LVAD support offers better functional status and discharge rates, it is associated with a higher risk of stroke.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Transplant Medicine

Background:

  • Improved survival with pediatric left ventricular assist devices (LVADs) shifts focus to quality of life and functional status (FS).
  • Limited data exist on the functional status of children supported by LVADs.
  • This study compares FS in children supported by LVADs versus vasoactive infusions.

Purpose of the Study:

  • To compare the functional status of children supported with LVADs versus vasoactive infusions.
  • To inform decision-making regarding optimal support strategies for pediatric heart failure.
  • To evaluate quality of life indicators beyond mortality.

Main Methods:

  • Utilized Organ Procurement and Transplant Network data (2006-2015).
  • Identified US children (1-21 years) with dilated cardiomyopathy undergoing heart transplant.
  • Assessed functional status using the Karnofsky and Lansky scale.

Main Results:

  • Children supported with LVADs showed higher FS at heart transplant (6 vs 5, p < 0.001) but lower FS at listing (4 vs 6, p < 0.001).
  • LVAD support was associated with higher discharge rates (46% vs 26%, p = 0.001).
  • Stroke prevalence was higher in the LVAD group at heart transplant (3% vs 1%, p = 0.04).

Conclusions:

  • Pediatric LVAD support is linked to improved functional status at heart transplant compared to vasoactive infusions.
  • LVADs facilitate higher hospital discharge rates post-transplant.
  • Increased stroke risk is a consideration for pediatric LVAD recipients.
Abstract